About OraSure Technologies
OraSure Technologies is a company based in Bethlehem (United States) founded in 1987. It operates as a Direct-to-Consumer (D2C), Reseller / Distribution, and HealthTech. The company has 501 employees as of December 31, 2024. OraSure Technologies has completed 6 acquisitions, including CoreBiome, DNA Genotek and Diversigen. OraSure Technologies offers products and services including Rapid Diagnostic Tests and Sample Collection Devices. OraSure Technologies operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, Quantalife, Senzo and Hememics Biotechnologies, among others.
- Headquarter Bethlehem, United States
- Employees 501 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Orasure Technologies, Inc.
-
Annual Revenue
$185.83 M-54.17as on Dec 31, 2024
-
Net Profit
$-19.5 M-136.34as on Dec 31, 2024
-
EBITDA
$-9.73 M-113.15as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Gates Foundation
& 2 more
-
Employee Count
501
as on Dec 31, 2024
-
Investments & Acquisitions
CoreBiome
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OraSure Technologies
OraSure Technologies is a publicly listed company on the NASDAQ with ticker symbol OSUR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of OraSure Technologies
OraSure Technologies offers a comprehensive portfolio of products and services, including Rapid Diagnostic Tests and Sample Collection Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid tests for detecting critical medical conditions are provided.
Devices for sample collection and stabilization are offered globally.
Unlock access to complete
Unlock access to complete
Leadership Team
24 people
Sales and Marketing
12 people
Senior Team
9 people
Software Development Team
9 people
Product Management Team
7 people
Finance and Accounting
7 people
Operations Team
4 people
Human Resources and Administration
4 people
Unlock access to complete
Funding Insights of OraSure Technologies
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(17 Jul 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Grant - OraSure Technologies | Valuation |
investors |
|
| Jun, 2017 | Amount | Grant - OraSure Technologies | Valuation |
investors |
|
| Jul, 2012 | Amount | Grant - OraSure Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OraSure Technologies
OraSure Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, HHS and Public Health Emergency. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OraSure Technologies
OraSure Technologies has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include CoreBiome, DNA Genotek and Diversigen. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Sherlock Biosciences is focused on molecular diagnostics development.
|
2019 | ||||
|
Microbiome diversity is analyzed using big data methods.
|
2016 | ||||
|
Non-invasive urine test for HIV PrEP adherence monitoring is developed.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - OraSure Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orasure Technologies Comparisons
Competitors of OraSure Technologies
OraSure Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, Quantalife, Senzo and Hememics Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| domain | founded_year | HQ Location |
Point of care diagnostic platform and data management system
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orasure Technologies
Frequently Asked Questions about OraSure Technologies
When was OraSure Technologies founded?
OraSure Technologies was founded in 1987 and raised its 1st funding round 25 years after it was founded.
Where is OraSure Technologies located?
OraSure Technologies is headquartered in Bethlehem, United States.
Who is the current CEO of OraSure Technologies?
Douglas A. Michels is the current CEO of OraSure Technologies.
How many employees does OraSure Technologies have?
As of Dec 31, 2024, the latest employee count at OraSure Technologies is 501.
What is the annual revenue of OraSure Technologies?
Annual revenue of OraSure Technologies is $185.83M as on Dec 31, 2024.
What does OraSure Technologies do?
OraSure Technologies, Inc. is involved in the development, manufacture, and distribution of rapid diagnostic tests and sample collection solutions. The company operates within the healthcare sector, focusing on improving access, quality, and value of medical services. Products are distributed globally to clinical laboratories, hospitals, clinics, public health organizations, and direct to consumers. Subsidiaries like DNA Genotek and Sherlock Biosciences contribute to innovative solutions for detecting critical medical conditions such as HIV, HCV, and syphilis.
Who are the top competitors of OraSure Technologies?
OraSure Technologies's top competitors include Souzhou Ribo Life Science, Quantalife and Senzo.
What products or services does OraSure Technologies offer?
OraSure Technologies offers Rapid Diagnostic Tests and Sample Collection Devices.
Is OraSure Technologies publicly traded?
Yes, OraSure Technologies is publicly traded on NASDAQ under the ticker symbol OSUR.
How many acquisitions has OraSure Technologies made?
OraSure Technologies has made 6 acquisitions, including CoreBiome, DNA Genotek, and Diversigen.
Who are OraSure Technologies's investors?
OraSure Technologies has 3 investors. Key investors include Gates Foundation, HHS, and Public Health Emergency.
What is OraSure Technologies's ticker symbol?
The ticker symbol of OraSure Technologies is OSUR on NASDAQ.